Gabrielle Y. Liu

ORCID: 0000-0003-2049-4231
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Respiratory viral infections research
  • Pneumonia and Respiratory Infections
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Respiratory and Cough-Related Research
  • Emergency and Acute Care Studies
  • Inhalation and Respiratory Drug Delivery
  • Lung Cancer Diagnosis and Treatment
  • Air Quality and Health Impacts
  • Frailty in Older Adults
  • Respiratory Support and Mechanisms
  • interferon and immune responses
  • Occupational exposure and asthma
  • Vasculitis and related conditions
  • SARS-CoV-2 detection and testing
  • Cardiovascular Effects of Exercise
  • Atherosclerosis and Cardiovascular Diseases
  • Advanced biosensing and bioanalysis techniques
  • Pediatric health and respiratory diseases
  • Injury Epidemiology and Prevention
  • Cardiovascular and exercise physiology
  • COVID-19 diagnosis using AI
  • Pleural and Pulmonary Diseases

Northwestern University
2021-2024

University of California, Davis
2024

Pulmonary and Critical Care Associates
2023

University of California, San Francisco
2019

Rogan A. Grant Luisa Morales‐Nebreda Nikolay S. Markov Suchitra Swaminathan Melissa Querrey and 95 more Estefany Rios-Guzman Darryl A. Abbott Helen K. Donnelly Alvaro Donayre Isaac A. Goldberg Zasu M. Klug Nicole Borkowski Ziyan Lu Hermon Kihshen Yuliya Politanska Lango Sichizya Mengjia Kang Ali Shilatifard Chao Qi Jon W. Lomasney A. Christine Argento Jacqueline M. Kruser Elizabeth S. Malsin Chiagozie I. Pickens Sean B. Smith James M. Walter Anna Pawlowski Daniel Schneider Prasanth Nannapaneni Hiam Abdala‐Valencia Ankit Bharat Cara J. Gottardi G. R. Scott Budinger Alexander V. Misharin Benjamin D. Singer Richard G. Wunderink Rogan A. Grant Luisa Morales‐Nebreda Nikolay S. Markov Suchitra Swaminathan Melissa Querrey Estefany Rios-Guzman Darryl A. Abbott Helen K. Donnelly Alvaro Donayre Isaac A. Goldberg Zasu M. Klug Nicole Borkowski Ziyan Lu Hermon Kihshen Yuliya Politanska Lango Sichizya Mengjia Kang Ali Shilatifard Chao Qi Jon W. Lomasney A. Christine Argento Jacqueline M. Kruser Elizabeth S. Malsin Chiagozie I. Pickens Sean B. Smith James M. Walter Anna Pawlowski Daniel Schneider Prasanth Nannapaneni Hiam Abdala‐Valencia Ankit Bharat Cara J. Gottardi G. R. Scott Budinger Alexander V. Misharin Benjamin D. Singer Richard G. Wunderink Ajay A. Wagh Alan R. Hauser Alexis Rose Wolfe Anjali Thakrar Anjana V. Yeldandi Ann A. Wang Anne R. Levenson Anthony M. Joudi Betty T. Tran Catherine A. Gao Chitaru Kurihara Clara Schroedl Curt M. Horvath Daniel Meza David D. Odell David W. Kamp Deborah R. Winter Egon A. Ozer Elisheva D. Shanes Elizabeth T. Bartom Emily J. Rendleman Emily M. Leibenguth Firas Wehbe Gabrielle Y. Liu Gaurav Gadhvi Heliodoro Tejedor Navarro Jacob I. Sznajder Jane E. Dematte

10.1038/s41586-020-03148-w article EN other-oa Nature 2021-01-11

Rationale: Current guidelines recommend patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia receive empirical antibiotics for suspected bacterial superinfection on the basis of weak evidence. Rates ventilator-associated (VAP) in clinical trials SARS-CoV-2 are unexpectedly low. Objectives: We conducted an observational single-center study to determine prevalence and etiology at time initial intubation incidence subsequent VAP pneumonia. Methods: Bronchoscopic...

10.1164/rccm.202106-1354oc article EN cc-by-nc-nd American Journal of Respiratory and Critical Care Medicine 2021-08-19

Abstract Despite the wide effects of cardiorespiratory fitness (CRF) on metabolic, cardiovascular, pulmonary and neurological health, challenges in feasibility reproducibility CRF measurements have impeded its use for clinical decision-making. Here we link proteomic profiles to 14,145 individuals across four international cohorts with diverse ascertainment methods establish, validate characterize a score. In cohort around 22,000 UK Biobank, score was associated reduced risk all-cause...

10.1038/s41591-024-03039-x article EN cc-by Nature Medicine 2024-06-01
Nikolay S. Markov Ziyou Ren Karolina J. Senkow Rogan A. Grant Catherine A. Gao and 95 more Elizabeth S. Malsin Lango Sichizya Hermon Kihshen Kathryn A. Helmin Milica Jovisic Jason Arnold Xochítl G. Pérez-Leonor Hiam Abdala‐Valencia Suchitra Swaminathan Julu Nwaezeapu Mengjia Kang Luke V. Rasmussen Egon A. Ozer Ramon Lorenzo‐Redondo Judd F. Hultquist Lacy M. Simons Estefany Rios-Guzman Alexander V. Misharin Richard G. Wunderink G. R. Scott Budinger Benjamin D. Singer Luisa Morales‐Nebreda Hiam Abdala‐Valencia Luke V. Rasmussen Judd F. Hultquist Lacy Simmons Estefany Rios-Guzman Michael Alexander Arghavan Alisoltani Joseph I. Bailey Elizabeth T. Bartom Ankit Bharat Thomas Bolig Nicole Borkowski Navdeep S. Chandel Katie Clepp John M. Coleman Michael J. Cuttica Thaddeus R. Cybulski Jane E. Dematte Joseph S. Deters Estefani Diaz Alvaro Donayre Helen K. Donnelly Justin A. Fiala Gaurav Gadhvi Khalilah L. Gates Samuel W. M. Gatesy Pearl D. Go Cara J. Gottardi Stefan J. Green Elen Gusman SeungHye Han Erica M. Hartmann Alan R. Hauser Curt M. Horvath Mishaal Hukamdad Sydney M. Hyder Manu Jain Emmy Jonasson Anthony M. Joudi Rachel Kadar Ravi Kalhan David W. Kamp Manoj Kandpal David A. Kidd Zasu M. Klug E. Korth Jacqueline M. Kruser Romy Lawrence Emily M. Leibenguth Anne R. Levenson Lindsey D. Gradone Gabrielle Y. Liu Jon W. Lomasney Theresa A. Lombardo Ziyan Lu Amy Ludwig Ali Mahmoud Alexandra C. McQuattie‐Pimentel Daniel Meza R. Mylvaganam Prasanth Nannapaneni Sophia Nozick Luı́s A. Nunes Amaral Radhika A. Patel Anna Pawlowski Chiagozie I. Pickens Yuliya Politanska Taylor A. Poor Michelle Prickett Chao Qi Melissa Querrey Karen M. Ridge Madeline L. Rosenbaum

10.1038/s41590-024-01914-w article EN Nature Immunology 2024-08-13

Quantitative interstitial abnormalities (QIAs) are early measures of lung injury automatically detected on chest computed tomography scans. QIAs associated with impaired respiratory health and share features advanced diseases, but their biological underpinnings not well understood.

10.1164/rccm.202307-1129oc article EN American Journal of Respiratory and Critical Care Medicine 2024-01-29

Current genetic discovery methods are largely restricted to profiling circulating molecules or architecture, limited in use of tissue-based molecular genetics identify pathogenic and therapeutic targets. Here, we leverage a multi-level platform integrating population-level proteomics with functional genomic analyses based on human coronary artery tissue reveal determinants disease susceptibility. Using aptamer-based (~7,000 aptamers) across ~3,000 individuals, first identified the proteome...

10.1101/2025.03.06.25323506 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2025-03-07

Introduction Visually normal areas of the lung with high attenuation on computed tomography (CT) imaging, termed CT injury, may represent injured but not yet remodelled parenchyma. This prospective cohort study examined if injury is associated future interstitial features and restrictive spirometry abnormality among participants from Coronary Artery Risk Development in Young Adults (CARDIA) study. Methods CARDIA a population-based scans obtained at two time points were assessed objectively...

10.1183/23120541.00004-2023 article EN cc-by-nc ERJ Open Research 2023-04-20

Accelerated decline in lung function is associated with incident COPD, hospitalizations and death. However, identifying this trajectory longitudinal spirometry measurements challenging clinical practice.

10.1164/rccm.202403-0613oc article EN American Journal of Respiratory and Critical Care Medicine 2024-09-10
Roxane Rohani Marc H. Scheetz Helen K. Donnelly Alvaro Donayre Mengjia Kang and 95 more Estefani Diaz Kay Dedicatoria Alan R. Hauser Egon A. Ozer Sophia Nozick Chao Qi Anna Pawlowski Michael Neely Alexander V. Misharin Richard G. Wunderink Nathaniel J. Rhodes Hiam Abdala‐Valencia Michael Alexander Jason Arnold Joseph I. Bailey Elizabeth T. Bartom Ankit Bharat Thomas Bolig Nicole Borkowski G. R. Scott Budinger Navdeep S. Chandel Rebecca K Clepp John R. Coleman Michael J. Cuttica Thaddeus R. Cybulski Jane E. Dematte Joseph S. Deters Justin A Fiala Gaurav T Gadhvi Catherine A. Gao Khalilah L. Gates Samuel W. M. Gatesy Ritika Giri Pearl D. Go Cara J. Gottardi Rogan A. Grant Stefan J. Green Elen Gusman Estefany Rios-Guzman SeungHye Han Erica M. Hartmann Curt M. Horvath Mishaal Hukamdad Sydney M. Hyder Manu Jain Anthony M. Joudi Rachel Kadar Ravi Kalhan David W. Kamp Manoj Kandpal David A. Kidd Hermon Kihshen Zasu M. Klug E. Korth Jacqueline M. Kruser Romy Lawrence Emily M. Leibenguth Anne R. Levenson Lindsey D. Gradone Gabrielle Y. Liu Jon W. Lomasney Theresa A. Lombardo Ziyan Lu Amy Ludwig Ali Mahmoud Elizabeth S. Malsin Nikolay S. Markov Alexandra C. McQuattie‐Pimentel Daniel Meza Felix Leonardo Morales Luisa Morales‐Nebreda Richard I. Morimoto R. Mylvaganam Prasanth Nannapaneni Luı́s A. Nunes Amaral Radhika A. Patel Lorenzo L. Pesce Chiagozie I. Pickens Yuliya Politanska Taylor A. Poor Michelle Prickett Melissa Querrey Luke V. Rasmussen Ziyou Ren Karen M. Ridge Madeline L Rosenbaum Sharon R Rosenberg Timothy Rowe Susan Russell Marc A. Sala Daniel Schneider Clara Schroedl Katharine Secunda Patrick C. Seed Karolina J. Senkow

Abstract Objectives Critical illness reduces β-lactam pharmacokinetic/pharmacodynamic (PK/PD) attainment. We sought to quantify PK/PD attainment in patients with hospital-acquired pneumonia. Methods Meropenem plasma PK data (n = 70 patients) were modelled, rates calculated for empirical and definitive targets, between-patient variability was quantified [as a coefficient of variation (CV%)]. Results Attainment 100% T>4×MIC variable both (CV% 92) directed 33%) treatment. Conclusions...

10.1093/jac/dkac245 article EN Journal of Antimicrobial Chemotherapy 2022-07-23
Coming Soon ...